Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 4
2013 7
2014 4
2015 5
2016 6
2017 4
2018 5
2019 11
2020 7
2021 10
2022 7
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
The Future of Somatostatin Receptor Ligands in Acromegaly.
Gadelha MR, Wildemberg LE, Kasuki L. Gadelha MR, et al. Among authors: kasuki l. J Clin Endocrinol Metab. 2022 Jan 18;107(2):297-308. doi: 10.1210/clinem/dgab726. J Clin Endocrinol Metab. 2022. PMID: 34618894 Free PMC article. Review.
Refractory somatotroph adenomas.
Gadelha MR, Kasuki L. Gadelha MR, et al. Among authors: kasuki l. Pituitary. 2023 Jun;26(3):266-268. doi: 10.1007/s11102-023-01324-5. Epub 2023 Jun 15. Pituitary. 2023. PMID: 37316636 Review.
Innovative therapeutics in acromegaly.
Kasuki L, Gadelha MR. Kasuki L, et al. Best Pract Res Clin Endocrinol Metab. 2022 Dec;36(6):101679. doi: 10.1016/j.beem.2022.101679. Epub 2022 May 27. Best Pract Res Clin Endocrinol Metab. 2022. PMID: 35688725 Review.
Editorial: Rising stars in translational endocrinology.
Kasuki L. Kasuki L. Front Endocrinol (Lausanne). 2023 Aug 11;14:1266825. doi: 10.3389/fendo.2023.1266825. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37635960 Free PMC article. No abstract available.
Novel therapies for acromegaly.
Maia B, Kasuki L, Gadelha MR. Maia B, et al. Among authors: kasuki l. Endocr Connect. 2020 Dec;9(12):R274-R285. doi: 10.1530/EC-20-0433. Endocr Connect. 2020. PMID: 33434151 Free PMC article. Review.
Management of pituitary incidentaloma.
Boguszewski CL, de Castro Musolino NR, Kasuki L. Boguszewski CL, et al. Among authors: kasuki l. Best Pract Res Clin Endocrinol Metab. 2019 Apr;33(2):101268. doi: 10.1016/j.beem.2019.04.002. Epub 2019 Apr 13. Best Pract Res Clin Endocrinol Metab. 2019. PMID: 31027975 Review.
Biomarkers of response to treatment in acromegaly.
Kasuki L, Lamback E, Antunes X, Gadelha MR. Kasuki L, et al. Expert Rev Endocrinol Metab. 2024 Jan-May;19(1):71-80. doi: 10.1080/17446651.2023.2293107. Epub 2024 Jan 1. Expert Rev Endocrinol Metab. 2024. PMID: 38078447 Review.
The genetic background of acromegaly.
Gadelha MR, Kasuki L, Korbonits M. Gadelha MR, et al. Among authors: kasuki l. Pituitary. 2017 Feb;20(1):10-21. doi: 10.1007/s11102-017-0789-7. Pituitary. 2017. PMID: 28161730 Free PMC article. Review.
Acromegaly and Colorectal Neoplasm: An Update.
Kasuki L, Maia B, Gadelha MR. Kasuki L, et al. Front Endocrinol (Lausanne). 2022 Jun 20;13:924952. doi: 10.3389/fendo.2022.924952. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35795151 Free PMC article. Review.
New Treatments for Acromegaly in Development.
Gadelha MR, Gadelha AC, Kasuki L. Gadelha MR, et al. Among authors: kasuki l. J Clin Endocrinol Metab. 2024 Mar 15;109(4):e1323-e1327. doi: 10.1210/clinem/dgad568. J Clin Endocrinol Metab. 2024. PMID: 37757837 Free PMC article.
73 results